NAPSR CNPR Final Exam Questions and Answers |Fall
2025/2026 Update | 100% Correct
QUESTION 1:
Which federal law primarily governs the promotion of prescription drugs by pharmaceutical
representatives in the United States?
A) The Sherman Antitrust Act
B) The Pure Food and Drug Act
C) The Food, Drug, and Cosmetic Act
D) The Drug Price Competition and Patent Term Restoration Act
CORRECT ANSWER: C
RATIONALE: The Food, Drug, and Cosmetic Act (FD&C Act) provides the legal framework by
which the FDA regulates drug labeling and marketing to ensure safety, efficacy, and truthful
promotion. The other acts deal with different areas of regulation.
QUESTION 2:
What phase of clinical trials focuses primarily on assessing a drug’s efficacy in patients with
the target condition?
A) Phase I
B) Phase II
C) Phase III
D) Phase IV
CORRECT ANSWER: C
RATIONALE: Phase III trials are large-scale studies designed to confirm a drug’s effectiveness
and monitor adverse effects compared with existing treatments, a prerequisite for regulatory
approval.
QUESTION 3:
A pharmaceutical sales representative should avoid discussing:
A) Approved indications
B) Dosing guidelines per the label
C) Off-label uses
D) Side effects listed in the package insert
CORRECT ANSWER: C
RATIONALE: “Off-label” promotion is prohibited by FDA regulation. Representatives must
confine discussions to on-label, approved information only.
QUESTION 4:
In pharmacology, “bioavailability” refers to:
A) The degree to which a drug is excreted unchanged
B) The proportion of a drug that enters the systemic circulation unchanged
C) The rate of metabolism by the liver
,D) The affinity of the drug for receptor sites
CORRECT ANSWER: B
RATIONALE: Bioavailability quantifies how much of an administered dose reaches systemic
circulation intact, determining dosage effectiveness.
QUESTION 5:
Which organization assigns the nonproprietary (generic) name to a drug in the United
States?
A) FDA
B) United States Pharmacopeia (USP)
C) American Medical Association (AMA)
D) United States Adopted Names (USAN) Council
CORRECT ANSWER: D
RATIONALE: The USAN Council designates unique, standardized nonproprietary drug
names. Accuracy in drug naming prevents confusion in the marketplace.
QUESTION 6:
What is the primary purpose of pharmacovigilance programs?
A) Drug discovery
B) Post-marketing safety monitoring
C) Market share forecasting
D) Dosage form development
CORRECT ANSWER: B
RATIONALE: Pharmacovigilance ensures ongoing safety by collecting and analyzing reports
of adverse drug reactions after market approval.
QUESTION 7:
Which type of drug name is used in marketing and promotion to physicians?
A) Chemical name
B) Generic name
C) Brand name
D) Experimental code
CORRECT ANSWER: C
RATIONALE: Brand (trade) names are created by pharmaceutical companies for commercial
use, making products easier to remember and distinguish.
QUESTION 8:
When meeting with a physician, a professional pharmaceutical representative should first:
A) Begin with a full product presentation
B) Ask open-ended questions to understand office needs
,C) Focus discussion only on price
D) Provide samples immediately
CORRECT ANSWER: B
RATIONALE: Effective selling begins with listening. Asking open questions helps tailor
discussions to the healthcare provider’s preferences and patient population.
QUESTION 9:
Which government agency enforces regulations regarding prescription drug marketing
practices?
A) CDC
B) NIH
C) FDA
D) CMS
CORRECT ANSWER: C
RATIONALE: The FDA oversees all prescription drug marketing to ensure accuracy and
prevent misleading or unsubstantiated claims.
QUESTION 10:
A “black box warning” on a package insert indicates:
A) The drug is under patent litigation
B) The medication requires refrigeration
C) The presence of serious or life-threatening risks
D) Over-the-counter status
CORRECT ANSWER: C
RATIONALE: A boxed warning is the strongest caution the FDA mandates, signaling serious
or potentially fatal adverse effects.
QUESTION 11:
Which of the following best describes “drug half-life”?
A) The time needed for absorption to begin
B) The period required for the plasma concentration to decrease by 50%
C) The time between administration and peak effect
D) The duration a drug remains bound to plasma proteins
CORRECT ANSWER: B
RATIONALE: Half-life reflects how quickly a drug is eliminated from the body and determines
appropriate dosing frequency.
QUESTION 12:
The term “first-pass metabolism” refers to drug metabolism that occurs primarily in:
A) The kidneys
B) The lungs
, C) The liver
D) The intestines
CORRECT ANSWER: C
RATIONALE: First-pass metabolism happens in the liver, where orally administered drugs are
significantly metabolized before reaching systemic circulation.
QUESTION 13:
Which of the following is an example of a Schedule II controlled substance?
A) Diazepam
B) Codeine combination cough syrup
C) Oxycodone
D) Alprazolam
CORRECT ANSWER: C
RATIONALE: Oxycodone has a high potential for abuse but accepted medical use, thereby
classified as Schedule II under DEA regulations.
QUESTION 14:
Which regulatory submission contains the results of all preclinical and clinical tests
required for FDA approval of a new drug?
A) IND
B) NDA
C) ANDA
D) DMF
CORRECT ANSWER: B
RATIONALE: A New Drug Application (NDA) compiles all research, safety, and efficacy data
necessary for marketing approval.
QUESTION 15:
The primary role of a pharmaceutical sales representative is to:
A) Prescribe medications
B) Diagnose medical conditions
C) Ethically promote products and provide clinical information
D) Determine formulary placement
CORRECT ANSWER: C
RATIONALE: Representatives inform healthcare professionals, ensuring promotion is
compliant, informative, and non-prescriptive.
QUESTION 16:
Which document summarizes the clinical and pharmacological information approved by
the FDA for a particular drug?
2025/2026 Update | 100% Correct
QUESTION 1:
Which federal law primarily governs the promotion of prescription drugs by pharmaceutical
representatives in the United States?
A) The Sherman Antitrust Act
B) The Pure Food and Drug Act
C) The Food, Drug, and Cosmetic Act
D) The Drug Price Competition and Patent Term Restoration Act
CORRECT ANSWER: C
RATIONALE: The Food, Drug, and Cosmetic Act (FD&C Act) provides the legal framework by
which the FDA regulates drug labeling and marketing to ensure safety, efficacy, and truthful
promotion. The other acts deal with different areas of regulation.
QUESTION 2:
What phase of clinical trials focuses primarily on assessing a drug’s efficacy in patients with
the target condition?
A) Phase I
B) Phase II
C) Phase III
D) Phase IV
CORRECT ANSWER: C
RATIONALE: Phase III trials are large-scale studies designed to confirm a drug’s effectiveness
and monitor adverse effects compared with existing treatments, a prerequisite for regulatory
approval.
QUESTION 3:
A pharmaceutical sales representative should avoid discussing:
A) Approved indications
B) Dosing guidelines per the label
C) Off-label uses
D) Side effects listed in the package insert
CORRECT ANSWER: C
RATIONALE: “Off-label” promotion is prohibited by FDA regulation. Representatives must
confine discussions to on-label, approved information only.
QUESTION 4:
In pharmacology, “bioavailability” refers to:
A) The degree to which a drug is excreted unchanged
B) The proportion of a drug that enters the systemic circulation unchanged
C) The rate of metabolism by the liver
,D) The affinity of the drug for receptor sites
CORRECT ANSWER: B
RATIONALE: Bioavailability quantifies how much of an administered dose reaches systemic
circulation intact, determining dosage effectiveness.
QUESTION 5:
Which organization assigns the nonproprietary (generic) name to a drug in the United
States?
A) FDA
B) United States Pharmacopeia (USP)
C) American Medical Association (AMA)
D) United States Adopted Names (USAN) Council
CORRECT ANSWER: D
RATIONALE: The USAN Council designates unique, standardized nonproprietary drug
names. Accuracy in drug naming prevents confusion in the marketplace.
QUESTION 6:
What is the primary purpose of pharmacovigilance programs?
A) Drug discovery
B) Post-marketing safety monitoring
C) Market share forecasting
D) Dosage form development
CORRECT ANSWER: B
RATIONALE: Pharmacovigilance ensures ongoing safety by collecting and analyzing reports
of adverse drug reactions after market approval.
QUESTION 7:
Which type of drug name is used in marketing and promotion to physicians?
A) Chemical name
B) Generic name
C) Brand name
D) Experimental code
CORRECT ANSWER: C
RATIONALE: Brand (trade) names are created by pharmaceutical companies for commercial
use, making products easier to remember and distinguish.
QUESTION 8:
When meeting with a physician, a professional pharmaceutical representative should first:
A) Begin with a full product presentation
B) Ask open-ended questions to understand office needs
,C) Focus discussion only on price
D) Provide samples immediately
CORRECT ANSWER: B
RATIONALE: Effective selling begins with listening. Asking open questions helps tailor
discussions to the healthcare provider’s preferences and patient population.
QUESTION 9:
Which government agency enforces regulations regarding prescription drug marketing
practices?
A) CDC
B) NIH
C) FDA
D) CMS
CORRECT ANSWER: C
RATIONALE: The FDA oversees all prescription drug marketing to ensure accuracy and
prevent misleading or unsubstantiated claims.
QUESTION 10:
A “black box warning” on a package insert indicates:
A) The drug is under patent litigation
B) The medication requires refrigeration
C) The presence of serious or life-threatening risks
D) Over-the-counter status
CORRECT ANSWER: C
RATIONALE: A boxed warning is the strongest caution the FDA mandates, signaling serious
or potentially fatal adverse effects.
QUESTION 11:
Which of the following best describes “drug half-life”?
A) The time needed for absorption to begin
B) The period required for the plasma concentration to decrease by 50%
C) The time between administration and peak effect
D) The duration a drug remains bound to plasma proteins
CORRECT ANSWER: B
RATIONALE: Half-life reflects how quickly a drug is eliminated from the body and determines
appropriate dosing frequency.
QUESTION 12:
The term “first-pass metabolism” refers to drug metabolism that occurs primarily in:
A) The kidneys
B) The lungs
, C) The liver
D) The intestines
CORRECT ANSWER: C
RATIONALE: First-pass metabolism happens in the liver, where orally administered drugs are
significantly metabolized before reaching systemic circulation.
QUESTION 13:
Which of the following is an example of a Schedule II controlled substance?
A) Diazepam
B) Codeine combination cough syrup
C) Oxycodone
D) Alprazolam
CORRECT ANSWER: C
RATIONALE: Oxycodone has a high potential for abuse but accepted medical use, thereby
classified as Schedule II under DEA regulations.
QUESTION 14:
Which regulatory submission contains the results of all preclinical and clinical tests
required for FDA approval of a new drug?
A) IND
B) NDA
C) ANDA
D) DMF
CORRECT ANSWER: B
RATIONALE: A New Drug Application (NDA) compiles all research, safety, and efficacy data
necessary for marketing approval.
QUESTION 15:
The primary role of a pharmaceutical sales representative is to:
A) Prescribe medications
B) Diagnose medical conditions
C) Ethically promote products and provide clinical information
D) Determine formulary placement
CORRECT ANSWER: C
RATIONALE: Representatives inform healthcare professionals, ensuring promotion is
compliant, informative, and non-prescriptive.
QUESTION 16:
Which document summarizes the clinical and pharmacological information approved by
the FDA for a particular drug?
